Trials / Completed
CompletedNCT06668883
Novel Exhaled Breath Aerosol Collection Devices in Patients With Lower Respiratory Tract Infection - a Performance and Acceptability Study
Novel Exhaled Breath Aerosol Collection Devices in Patients With Lower Respiratory Tract Infection - a Performance and Acceptability Study (Acronym: AeroCAP)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 23 (actual)
- Sponsor
- Avelo AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess the performance of two novel breath collection devices and their subsequent detection of respiratory pathogens compared to sputum samples in patients with lower respiratory tract infections.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Sputum collection for molecular analysis | Sputum collection to be used with syndromic multiplex PCR testing |
| DEVICE | Breath and cough collection for molecular analysis | Breath and cough collection with two proprietary devices to be used with syndromic multiplex PCR testing |
Timeline
- Start date
- 2024-11-13
- Primary completion
- 2025-05-21
- Completion
- 2025-05-21
- First posted
- 2024-11-01
- Last updated
- 2025-08-08
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT06668883. Inclusion in this directory is not an endorsement.